Mindray acquires Dragonbio at $70 mn
20 July 2015 | News | By BioSpectrum Bureau
Mindray acquires Dragonbio at $70 mn
Mindray has acquired all stakes of Dragonbio at $70 mn
Singapore: China's Mindray Medical has acquired all stakes of Wuhan Dragonbio Surgical Implant for a total cash consideration of approx $70.2 millon (RMB 435 million).
The company now holds 100 percent of Dragonbio, a domestic medical orthopedic products provider of trauma, spine, joint and other surgical products.
